Proprietary Nutritionals Inc. (PRI; Kearny, NJ) has announced that its Cran-Max proprietary cranberry concentrate has been strengthened to 7.2% proanthocyanidins per 500 mg.
Proprietary Nutritionals Inc. (PRI; Kearny, NJ) has announced that its Cran-Max proprietary cranberry concentrate has been strengthened to 7.2% proanthocyanidins per 500 mg. This increase allows the ingredient to meet requirements for a French Food Safety Authority functional claim on urinary tract infections.
Published science has often indicated that cranberries provide an inhibiting effect on urinary tract infections (UTIs) in men and women, and UTI formulas often include the ingredient. In a recently published study on 137 women with UTI cases, daily supplementation of 500 mg of cranberry extract prevented UTI recurrence to a level nearly equal to that of Trimethoprim (a common antibiotic)-and with fewer reported adverse effects.
Cran-Max is a cranberry extract designed for efficient deliver of the ingredient to the human body. “[Cran-Max] is made with a proprietary process that utilizes all the vital parts of the cranberry: skin, seeds, pulp, juice and fiber,” said PRI in a recent press release. “It is the only cranberry concentrate made using the patented Bio-Shield technology that protects the cranberry from destruction by gastric acid, so that it can be delivered to the gastrointestinal tract for maximum effect.”
PRI is a subsidiary of Pharmachem Laboratories Inc. (Kearny, NJ). For more information, visit the company here.